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The history of the in situ saphenous vein bypass
John E. Connolly, MD, Orange, CalifIn 1948, Kunlin1 in France first described the use of a
long reversed saphenous vein to bypass occlusive disease of
the superficial femoral artery (SFA) in a patient suffering
from a necrotic ulcer of the foot despite the current treat-
ment of that time of sympathectomy and arterectomy. The
ulcer healed, which surprised his patron, Prof Leriche, very
much. However, because he was not involved in the idea or
application of this new surgical technique, he did not
promote its application and thus it was not immediately
widely known. It was not until 1962, when Linton and
Darling,2 in Boston, reported their application of Kunlin’s
reversed femoral-popliteal saphenous vein bypass, that its
application took off.
However, Charles Rob of London, as early as 1958,
questioned the technical and hemodynamic disadvantages
of the saphenous vein bypass when placed in a reversed
direction to obviate the vein valves. In 1959, he first used a
new technique3 for femoral-popliteal bypass in which the
saphenous vein was not reversed but was left in place by
destroying the competency of the valves from above with an
internal vein stripper. The branches of the vein were also
ligated to prevent subsequent adverse effects of arterio-
venous fistulas. Rob, however, did not pursue the in situ
procedure because he thought it was too time consuming,
and he thought the fistula problem outweighed the possi-
ble advantages of the technique.
Karl Victor Hall of Norway was a visiting fellow with
Rob at St. Mary’s Hospital in London at the time and
observed Rob perform one of these early in situ procedures.
When he returned home, he decided to pursue the tech-
nique more aggressively. Rather than destroy the compe-
tency of the valves, he opened the vein over each valve and
excised each valve (Fig 1). Hall reported his new in situ
technique in 1962.4 Impressed with his report, Connolly
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doi:10.1016/j.jvs.2010.05.018and Harris5 first introduced the in situ procedure in the
United States in 1963, using Rob’s technique of valve lysis
with an internal vein stripper to render the valves incompe-
tent (Fig 2, G). Subsequently, they used specially designed
long coronary dilators (Pilling and Co, Philadelphia, Pa) to
lyse the valves.
By not removing the saphenous vein in the in situ
procedure, it is not subjected to the trauma, vasoconstric-
tion, and rotation that is seen in the reversed femoral-
popliteal procedure. Likewise, the vascularity of the vasa
vasorum of the in situ veins is preserved.6 Perhaps the most
important advantage of the in situ procedure is that the
blood flow through the graft, which is dependent on the
square of the radius of the vessel, is not impeded but rather
accelerated by having the narrow end of the vein distal
instead of proximal. Gibson7 showed that flow is increased
with converging boundaries (nonreversed vein) but im-
peded with diverging boundaries (reversed vein).
These hemodynamic observations have increasing im-
portance as the taper of the vessel increases, as is the case
with longer vein grafts that are required to reach the tibial
vessels either in the calf or at the ankle. Thus, it was and
currently is our belief that the reversed saphenous vein graft
from the femoral to the popliteal artery has no significant
hemodynamic disadvantage because the vein is of compa-
rable diameter at the knee as in the groin. In contrast,
Fig 1. Venotomy with valve excision.bypass from the groin to the ankle strongly favors the in situ
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through a vein branch.
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above. (H)Hall and (I) Samuels introduced cutting valvulotomes from below; and (J)Leather used scissors introducedvalvulotome is engaged selectively in each cusp, and the cusp is divided.
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smaller vein below the knee, with better vein/artery size
match resulting in accelerated flow.
Themost controversial facet of the in situ operation has
been the question about what instrument is the best to lyse
the valves. Rob and Connolly initially used a vein stripper
from above down (Fig 2, G). Hall first excised each valve
through individual incisions, and later switched to a retro-
grade valvulotome, as did Samuels, Mills (Fig 2, J), and
Cartier (Fig 2, H).
Leather first used scissors passed through a vein branch
to cut the valves, and ultimately moved to the Mills valvu-
lotome 8 (Fig 3). Finally, the LeMaitre retrograde valvu-
lotome (Fig 4) appeared on themarket in 1983 and became
the most widely used valve-lysing instrument. LeMaitre
claims the advantage of his instrument is that it is self-sizing
and self-centering, and thus a more effective valvulotome,
especially with a 1.8-mm size. Whichever instrument was
used, the primary goal has been to do so with the least
amount of trauma and that an angiogram or endoscopy
have been used to check that the valves have been ade-
quately lysed. Likewise, the use of a handheld Doppler has
been introduced to identify venous tributaries.9
Although the in situ operation was first an open proce-
Fig 4. The LeMaitre retrograde valvulotome.dure, with a long skin incision to identify and ligate the veinbranches, complications of the long incision often included
pain, infection, and poor wound healing. Once the location
of tributaries could be accurately identified by Doppler
scanning, angiography, or angioscopy, the tributaries could
then be ligated through small local incisions. The early and
late results of the reversed saphenous femoral-popliteal
bypass and the in situ procedure limited to the popliteal
artery were similar,10 but this was not so with the in situ
procedure carried to the distal leg. Some vascular surgeons
continued to use a reverse saphenous vein bypass from the
groin to the ankle or foot, but the results were not compa-
rable to the distal in situ procedure. This was because in the
reversed distal vein bypass, a small-diameter vein was now
proximal and a large vein was distal, resulting in hemody-
namic decreased flow. Also, the magnitude of the long
reversed saphenous vein procedure was significant, with the
long incision and management of the excised vein. The
greatest contribution of the in situ procedure has clearly
been in its use to revascularize the lower leg.
An early publication by Barner et al11 in 1969 reported
much better results with reversed vein grafts than in situ
ones and tended to delay widespread acceptance of the in
situ procedure. Unfortunately, their experience with the in
situ procedure was just to the popliteal artery, whereas we
now know the special indication for the in situ procedure is
vein bypass to the lower leg. In 1981, Leather et al12 in
Albany began to accumulate a large series of in situ proce-
dures and reported impressive success. They attachedmuch
of their positive results to their method of valve lysis,
although they subsequently changed lysis instruments,
more recently using a Mills valvulotome. In 1982, Gruss et
al13 reported good results with 355 distal in situ bypasses in
the lower leg for advanced ischemic disease. They used
Hall’s valvulotome in all of their cases. The Albany group14
later reported a patency of 50% in long in situ bypass at 10
years. The degree of progression of disease in the distal leg
vessels of course influences ultimate patency.
It was finally beginning to be apparent that the primary
place for the in situ procedure was in vein bypass to the
distal leg for ischemia. It was also apparent that the saphe-
nous vein should be mapped preoperatively.15 Finally, al-
though there are various ways to lyse the vein valves, it was
important that the valves were examined for the adequacy
of the lysis by angiogram or endoscopy before the opera-
tion was completed.
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